Stock 4577 DAITO PHARMACEUTICAL CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News Daito Pharmaceutical Co.,Ltd.

Equities

4577

JP3486150000

Delayed Japan Exchange
Other stock markets
 02:00:00 2024-05-02 am EDT 		5-day change 1st Jan Change
2,502 JPY +0.08% Intraday chart for Daito Pharmaceutical Co.,Ltd. -0.64% +31.34%
Apr. 12 Daito Pharmaceutical Co.,Ltd. announces an Equity Buyback for 350,000 shares, representing 2.23% for ¥1,000 million. CI
Apr. 12 Daito Pharmaceutical Co.,Ltd. authorizes a Buyback Plan. CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Daito Pharmaceutical Co.,Ltd. announces an Equity Buyback for 350,000 shares, representing 2.23% for ¥1,000 million.
CI
Daito Pharmaceutical Co.,Ltd. authorizes a Buyback Plan.
CI
Tranche Update on Daito Pharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on January 12, 2024.
CI
Daito Pharmaceutical Co.,Ltd.'s Equity Buyback announced on January 12, 2024, has closed with 160,000 shares, representing 0.93% for ¥303.36 million.
CI
Daito Pharmaceutical Co.,Ltd. announces an Equity Buyback for 160,000 shares, representing 1.01% for ¥303.36 million.
CI
Daito Pharmaceutical Co.,Ltd. authorizes a Buyback Plan.
CI
Ex-dividend day for interim dividend
FA
Daito Pharmaceutical : Summary of Consolidated Financial Results for the Three Months Ended August 31, 2023 (Japanese GAAP)
PU
Daito Pharmaceutical Co.,Ltd. announces an Equity Buyback for 160 shares.
CI
Daito Pharmaceutical Co.,Ltd.'s Equity Buyback announced on September 14, 2023, has expired.
CI
Daito Pharmaceutical Co.,Ltd. authorizes a Buyback Plan.
CI
Split: 1.1 of 1
FA
Daito Pharmaceutical : Summary of Consolidated Financial Results for the Year Ended May 31, 2023 (Based on Japanese GAAP)
PU
Ex-dividend day for final dividend
FA
Ex-dividend day for interim dividend
FA
Ex-dividend day for final dividend
FA
Anniversary bonus dividend
FA
Ex-dividend day for interim dividend
FA
Daito Pharmaceutical Co.,Ltd. announced that it has received ¥13.351 million in funding from Daiwa Securities Co., Ltd., Investment Arm
CI
Daito Pharmaceutical Co.,Ltd. announced that it expects to receive ¥13.351 million in funding from Daiwa Securities Co., Ltd., Investment Arm
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 4577 Stock
  4. News Daito Pharmaceutical Co.,Ltd.